Investor Type | Firm |
Type of Fund | VC |
Industries | Software (Web Marketplace Saas..) • IT (& TMT) • BioTech • Hardware (& Manufacturing) • Energy • CleanTech • HealthTech (& Fitness) • Cannabis • Web Security (& Privacy) • Material Science • Medical Devices (& Hospital Services) • Real Estate (& Construction) • Healthcare (& Wellness) • Life Science • Mobile • Mobility • Pharmaceutical (& Medicine) • Restaurants • Woman Focused |
Stages | Early, Seed |
Investing | United States • Sweden • Denmark • Finland • Norway |
Investment Range | €500,000 - €25,000,000 |
Investment Sweet Spot | €500,000 |
Industrifonden is a Sweden-based venture capital fund devoted to investing in early-stage life science and technology companies. Focused on the Nordic region, they specialize in seeding and nurturing innovations across various sectors, including Software, IT, BioTech, Hardware, Energy, CleanTech, HealthTech, Cannabis, Web Security, Material Science, Medical Devices, Real Estate, Healthcare, Life Science, Mobile, Mobility, Pharmaceutical, Restaurants, and areas targeted towards women. With a philosophy deeply rooted in the transformative power of emerging technologies, Industrifonden is dedicated to investing in ventures that present unique, scalable solutions that improve society through breakthrough technologies and scientific advancements. Their investment strategy targets companies at the forefront of Deep Tech, such as those engaged in advanced materials, industry 4.0, energy solutions, quantum computing, AI, synthetic biology, and more. In the Life Science sector, they support products and services that meet unmet medical needs and exhibit a willingness to pay for innovations that make a clinical difference. Industrifonden's expertise shines in biotech, medtech, and healthtech investments. Transformative Tech is another focus area, where the fund looks for innovative business models and novel applications of established technologies poised for industrial transformation and sustainable value creation. They maintain a preference for B2B companies and seek founders with deep, credible insights within their focus areas. With a commitment to long-term investments, Industrifonden has been pivotal in supporting clinical and commercial goals of its portfolio companies, making strategic injections of capital, experience, and expertise that bolster growth and global scaling. The fund operates with an investment size ranging from a minimum of 500,000 to a maximum of 25,000,000 and prefers to be in the early and seed stages of a company's lifecycle.
We invest in three main areas: Deep Tech, Life Science, and Transformative Tech (primarily ventures with Swedish connection but also across Nordics): Deep Tech Science and emerging technologies that have the potential to fundamentally transform industries and societies. We focus on deep tech verticals like advanced materials, industry 4.0, energy, quantum computing, AI, synthetic biology, and more. Life Science We support the commercialisation of products and services, grounded in solid science, which convincingly address an unmet medical need, and where we also see a willingness to pay for innovation that makes a clinical difference. We have expertise, in particular, in biotech, medtech and healthtech. Transformative Tech Transformative Tech includes innovative business models and novel implementations of established technologies that enable industrial transformation and sustainable value creation. We are agnostic regarding industry verticals but stay within the B2B-space and look for founders with deep and credible insights within their focus area.